Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/28854
Title: DURABLE CLINICAL EFFICACY OF ALEMTUZUMAB IN PATIENTS WITH ACTIVE RRMS IN THE ABSENCE OF CONTINUOUS TREATMENT: 7-YEAR FOLLOW-UP OF CARE-MS I PATIENTS (TOPAZ STUDY)
Authors: McCombe, Pamela
Boyko, Alexey N.
DeSeze, Jerome
Hartung, Hans-Peter
Havrdova, Eva
Inshasi, Jihad Said
Montalban, Xavier
Pozzilli, Carlo
Selmaj, Krzysztof W.
Vermersch, Patrick
Melanson, Maria
Daizadeh, Nadia
Rodriguez, Claudio E.
VAN WIJMEERSCH, Bart 
Issue Date: 2018
Publisher: BMJ PUBLISHING GROUP
Source: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 89(6), p. E18-E19 (Art N° 044)
Notes: [McCombe, Pamela] Univ Queensland, Brisbane, Qld, Australia. [Boyko, Alexey N.] Pirogov Russian Natl Res Univ, Moscow, Russia. [Boyko, Alexey N.] Usupov Hosp, Demyelinating Dis Ctr, Moscow, Russia. [DeSeze, Jerome] Univ Strasbourg, Strasbourg, France. [Hartung, Hans-Peter] Heinrich Heine Univ, Dusseldorf, Germany. [Havrdova, Eva] Charles Univ Prague, Fac Med 1, Prague, Czech Republic. [Inshasi, Jihad Said] Rashid Hosp, Dubai, U Arab Emirates. [Inshasi, Jihad Said] Dubai Med Coll, Dubai, U Arab Emirates. [Montalban, Xavier] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada. [Montalban, Xavier] Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya Cemcat, Barcelona, Spain. [Pozzilli, Carlo] Univ Rome, Rome, Italy. [Selmaj, Krzysztof W.] Med Univ Lodz, Lodz, Poland. [Vermersch, Patrick] Univ Lille, Lille, France. [Melanson, Maria; Daizadeh, Nadia; Rodriguez, Claudio E.] Sanofi, Cambridge, MA USA. [Van Wijmeersch, Bart] Hasselt Univ, BIOMED, Rehabil & MS Ctr Overpelt, Hasselt, Belgium.
Document URI: http://hdl.handle.net/1942/28854
ISSN: 0022-3050
e-ISSN: 1468-330X
DOI: 10.1136/jnnp-2018-ANZAN.43
ISI #: 000438056200044
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Show full item record

Page view(s)

104
checked on Jul 9, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.